Charles L. Bennett, MD, PhD, is Associate Director of the Midwest Center for Health Services & Policy Research at the Jesse Brown VA Medical Center-Lakeside in Chicago, Illinois. He is also Codirector for the Cancer Control Program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Professor of Medicine at the Northwestern University Feinberg School of Medicine, located in Chicago, Illinois. Dr Bennett's clinical and research interests include adverse drug reactions; cancer navigation programs; prostate cancer; cancer prevention, screening, detection, and treatment; quality of cancer care; health policy; and minority issues for cancer patients. Dr Bennett is an active member on the practice and outcomes assessment committees for the American Society of Hematology, the Department of Veterans Affairs, the National Cancer Center Network, the American Society of Clinical Oncology, and the Eastern Cooperative Oncology Group. Dr Bennett is board certified in medical oncology and internal medicine. He received his MD degree from the University of Pennsylvania in Philadelphia and his PhD degree in Public Policy from the RAND Graduate School in Santa Monica, California.


Douglas B. Cines, MD, currently serves as Director of the Coagulation Laboratory, Co-Vice Chair of Laboratory Medicine and Vice Chair for Academics in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania in Philadelphia. Dr Cines received his medical degree from New York University School of Medicine and completed his internship and residency at North Carolina Memorial Hospital in Chapel Hill. He then completed a fellowship in Hematology/Oncology at the Hospital of the University of Pennsylvania. Dr Cines is a member of several professional and honorary societies and has served on many public advisory committees. He has both published in and served as a reviewer for journals such as Blood, Journal of the American Medical Association, Nature, the New England Journal of Medicine, Proceedings of the National Academy of Sciences, Science, and the Journal of Clinical Investigation. Dr Cines has authored over 140 original papers and over 60 review articles, editorials, and book chapters in immunohematology and coagulation.


Judith Karp, MD, is Professor of Oncology and Medicine and Director of the Leukemia Program within the Division of Hematologic Malignancies at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University in Baltimore, Maryland. Dr Karp received her medical degree from Stanford School of Medicine in California. She completed her internship at Stanford University Hospitals and her residency and fellowship at Johns Hopkins. Dr Karp's research interests include the development and testing of new therapies for adult acute leukemias. She has published over 60 articles and reviews, and she has been study chair for many clinical trials in acute leukemia and myelodysplastic syndromes.


Robert McMillan, MD, is Professor Emeritus in the Hematology Division of the Department of Molecular and Experimental Medicine at the Scripps Research Institute in La Jolla, California. Dr McMillan is an Emeritus for the Platelet Disorder Support Association. He received his medical degree from the University of Pennsylvania School of Medicine before completing an internship at Los Angeles County General Hospital, residencies at Queen's Hospital in Honolulu, Hawaii, and the VA Center at Wadsworth Hospital in Los Angeles, and a fellowship in Hematology at VA Center at Wadsworth Hospital. Dr McMillan is a member of several professional organizations, including the American Society of Hematology and the International Society of Thrombosis and Hemostasis. Much of Dr McMillan's work has focused on immune thrombocytopenic purpura, on which he has published over 70 articles and reviews, including several guideline articles for the American Society of Hematology.